National Accreditation Board Suspends All DNA Testing at D.C. Crime Lab
By Keith L. Alexander,
Washington Post
| 04. 27. 2015
Untitled Document
One of the national organizations that govern DNA laboratories has ordered the District’s new crime lab to immediately suspend all DNA casework after concluding that the lab’s procedures are “insufficient and inadequate.”
D.C. Mayor Muriel E. Bowser ordered the audit by the ANSI-ASQ National Accreditation Board last month after the U.S. attorney’s office said it had discovered numerous errors in some of the lab’s DNA analyses. The audit, which was published Friday, criticized the lab’s practices and said they were not in compliance with FBI standards. It ordered “at a minimum” the revalidation of test procedures, new interpretation guidelines for DNA mixture cases, additional training and competency testing of staff.
The DNA analysts at the District’s Department of Forensic Sciences, according to the audit, “were not competent and were using inadequate procedures.” The authors of the review said the lab must begin to address the concerns within 30 days.
Legal experts say the audit could trigger a further investigation of hundreds of District criminal cases — including murder, sexual assault and gun possession cases — that have involved...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...